ESSA Pharma Inc.

NasdaqCM:EPIX

Location

Market Cap

USD 76.79 M

Share Price

USD 1.73

Avg Daily Volume

162,368

Change (1 day)

2.37%

Change (1 year)

-65.26%

Change (YTD)

-3.35%

ESSA Pharma Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025

ESSA Pharma Inc. EBITDA is NA for the Trailing 12 Months (TTM) ending March 31, 2025. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • ESSA Pharma Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -27.63 M, a -4.50% change year over year.
  • ESSA Pharma Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -28.93 M, a -22.06% change year over year.
  • ESSA Pharma Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -37.12 M, a 29.88% change year over year.
  • ESSA Pharma Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -28.58 M, a 59.64% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
Loading...
NasdaqCM: EPIX

ESSA Pharma Inc.

CEO Dr. David Ross Parkinson M.D.
IPO Date March 13, 2015
Location Canada
Headquarters 999 West Broadway
Employees 35
Sector 🏥 Health Care
Industries
Description

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Similar companies

NOVO-B.CO

Novo Nordisk A/S

USD 73.32

-2.33%

ABBV

AbbVie Inc.

USD 185.30

-0.10%

RO.SW

Roche Holding AG

USD 336.78

-0.52%

ABT

Abbott Laboratories

USD 132.99

0.44%

NOVN.SW

Novartis AG

USD 115.96

-0.50%

AZN.L

AstraZeneca PLC

USD 140.24

-1.30%

MRK

Merck & Co., Inc.

USD 79.06

-0.29%

AMGN

Amgen Inc.

USD 289.33

-0.10%

BSX

Boston Scientific Corporation

USD 101.30

-0.07%

TMO

Thermo Fisher Scientific Inc.

USD 397.88

1.35%

PFE

Pfizer Inc.

USD 23.97

0.38%

GILD

Gilead Sciences, Inc.

USD 108.50

0.46%

SAN.PA

Sanofi

USD 95.88

0.36%

VRTX

Vertex Pharmaceuticals Incorporated

USD 440.87

-1.68%

BMY

Bristol-Myers Squibb Company

USD 46.86

0.04%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 49.19

-0.68%

GSK.L

GSK plc

USD 18.89

-2.25%

CSL.AX

CSL Limited

USD 154.82

0.08%

SHL.DE

Siemens Healthineers AG

USD 53.26

0.96%

REGN

Regeneron Pharmaceuticals, Inc.

USD 509.72

-0.75%

MRK.DE

MERCK Kommanditgesellschaft auf Aktien

USD 127.08

1.48%

207940.KS

Samsung Biologics Co.,Ltd.

USD 737.62

2.27%

BDX

Becton, Dickinson and Company

USD 168.42

-0.10%

600276.SS

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.23

0.75%

4502.T

Takeda Pharmaceutical Company Limited

USD 29.34

-0.64%

ALNY

Alnylam Pharmaceuticals, Inc.

USD 309.70

-0.84%

UCB.BR

UCB SA

USD 181.46

0.14%

GEHC

GE HealthCare Technologies Inc.

USD 71.28

-0.85%

A

Agilent Technologies, Inc.

USD 115.56

0.03%

RGC

Regencell Bioscience Holdings Limited

USD 38.01

-40.00%

BAYN.DE

Bayer AG

USD 30.75

-0.65%

068270.KS

Celltrion, Inc.

USD 117.76

1.81%

2359.HK

WuXi AppTec Co., Ltd.

USD 9.39

0.82%

22UA.F

BioNTech SE

USD 105.99

2.07%

NTRA

Natera, Inc.

USD 171.86

0.52%

LH

Laboratory Corporation of America Holdings

USD 261.88

0.19%

3692.HK

Hansoh Pharmaceutical Group Company Limited

USD 3.57

0.90%

RPRX

Royalty Pharma plc

USD 34.86

-0.14%

INSM

Insmed Incorporated

USD 102.68

3.24%

BIIB

Biogen Inc.

USD 127.04

0.40%

4503.T

Astellas Pharma Inc.

USD 9.25

-0.70%

BIM.PA

bioMérieux S.A.

USD 138.60

1.42%

1801.HK

Innovent Biologics, Inc.

USD 9.90

-0.96%

196170.KQ

ALTEOGEN Inc.

USD 283.14

1.33%

BAX

Baxter International Inc.

USD 29.99

0.64%

SMMT

Summit Therapeutics Inc.

USD 20.56

1.98%

4507.T

Shionogi & Co., Ltd.

USD 17.12

0.25%

ILMN

Illumina, Inc.

USD 90.49

0.26%

GMAB.CO

Genmab A/S

USD 212.20

-1.53%

StockViz Staff

June 22, 2025

Any question? Send us an email